What do you know about stroke?
Stroke, or more commonly known as brain infarct, is a cerebrovascular disease. It occurs when there is a rupture or blockage in a blood vessel, reducing the blood supply to the brain and preventing brain tissue from getting oxygen. As a consequence the nerve cells stop working/die in minutes.
In Spain:
In Andalusia:
And what impact would it have...
...to treat patients before arriving at the hospital?
A quick and simple blood test would be able to identify a stroke, as well as its typology. Furthermore, in case this is an ischemic one, the treatment can be started in the ambulance.
This leads to:
- Double the chance of being asymptomatic
- Tripling the possibility of independence
- Quadruple the chance of survival
About Biofast
What is the main objective?
Our aim is to develop a point-of-care (POC) device to validate a panel of biomarkers that differentiate ischemic and hemorrhagic stroke using a blood sample.
News
BIOFAST (ESOC-2021) results presentations for use by members of the BIOFAST study
PREDICTED CLINICAL BENEFIT OF USING A BLOOD RAPID TEST TO IDENTITY LVO PATIENTS AT THE AMBULANCE AND REFER THEM DIRECTLY TO A THROMBECTOMY CENTER
LVO-CHECK_ A RAPID POINT-OF-CARE BLOOD TEST TO REFER LVO PATIENTS FROM THE AMBULANCE TO THE THROMBECTOMY CENTER
Preliminary results of BIOFAST are presented at the congress of the American Association for Clinical Chemistry: AACC
Other worldwide networks working with stroke out of the hospital
Conferences at ESOC 2021
where BIOFAST results will be presented:
Charla #2206 – PREDICTED CLINICAL BENEFIT OF USING A BLOOD RAPID TEST TO IDENTITY LVO PATIENTS AT THE AMBULANCE AND REFER THEM DIRECTLY TO A THROMBECTOMY CENTER.
Charla #1955 – LVO-CHECK: A RAPID POINT-OF-CARE BLOOD TEST TO REFER LVO PATIENTS FROM THE AMBULANCE TO THE THROMBECTOMY CENTER.
Partners
